Bristol-Myers Squibb (BMY)
61.12
1.10 (1.83%)
At close: Mar 31, 2025, 3:59 PM
60.87
-0.40%
After-hours: Mar 31, 2025, 07:46 PM EDT
Revlimid Revenue
History
| Quarter | Value | Change | Growth |
|---|---|---|---|
| Jun 30, 2023 | 1.47B | -282M | -16.11% |
| Mar 31, 2023 | 1.75B | -510M | -22.57% |
| Dec 31, 2022 | 2.26B | -160M | -6.61% |
| Sep 30, 2022 | 2.42B | -81M | -3.24% |
| Jun 30, 2022 | 2.5B | 2.02B | +417.81% |
| Mar 31, 2022 | 483M | -62M | -11.38% |
| Dec 31, 2021 | 545M | 30M | +5.83% |
| Sep 30, 2021 | 515M | 5M | +0.98% |
| Jun 30, 2021 | 510M | n/a | n/a |
| Mar 31, 2021 | n/a | n/a | n/a |
| Dec 31, 2020 | n/a | n/a | n/a |
| Sep 30, 2020 | n/a | n/a | n/a |
| Jun 30, 2020 | n/a | n/a | n/a |
| Mar 31, 2020 | n/a | n/a | n/a |
| Dec 31, 2019 | n/a | n/a | n/a |
| Sep 30, 2019 | n/a | n/a | n/a |
| Jun 30, 2019 | n/a | n/a | n/a |
| Mar 31, 2019 | n/a | n/a | n/a |
| Dec 31, 2018 | n/a | n/a | n/a |
| Sep 30, 2018 | n/a | n/a | n/a |
| Jun 30, 2018 | n/a | n/a | n/a |
| Mar 31, 2018 | n/a | n/a | n/a |
| Dec 31, 2017 | n/a | n/a | n/a |
| Sep 30, 2017 | n/a | n/a | n/a |
| Jun 30, 2017 | n/a | n/a | n/a |
| Mar 31, 2017 | n/a | n/a | n/a |
| Dec 31, 2016 | n/a | n/a | n/a |
| Sep 30, 2016 | n/a | n/a | n/a |
| Jun 30, 2016 | n/a | n/a | n/a |
| Mar 31, 2016 | n/a | n/a | n/a |
| Dec 31, 2015 | n/a | n/a | n/a |
| Sep 30, 2015 | n/a | n/a | n/a |
| Jun 30, 2015 | n/a | n/a | n/a |
| Mar 31, 2015 | n/a | n/a | n/a |
| Dec 31, 2014 | n/a | n/a | n/a |
| Sep 30, 2014 | n/a | n/a | n/a |
| Jun 30, 2014 | n/a | n/a | n/a |
| Mar 31, 2014 | n/a | n/a | n/a |
| Dec 31, 2013 | n/a | n/a | n/a |
| Sep 30, 2013 | n/a | n/a | n/a |
| Jun 30, 2013 | n/a | n/a | n/a |